Search

Your search keyword '"Colmenero, Jordi"' showing total 395 results
Start Over Author "Colmenero, Jordi"
395 results on '"Colmenero, Jordi"'

1. Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework

Author

Duijzer, Renée, Bernts, Lucas H P, Geerts, Anja, van Hoek, Bart, Coenraad, Minneke J, Rovers, Chantal, Alvaro, Domenico, Kuijper, Ed J, Nevens, Frederik, Halbritter, Jan, Colmenero, Jordi, Kupcinskas, Juozas, Salih, Mahdi, Hogan, Marie C, Ronot, Maxime, Vilgrain, Valerie, Hanemaaijer, Nicolien M, Kamath, Patrick S, Strnad, Pavel, Taubert, Richard, Gansevoort, Ron T, Torra, Roser, Nadalin, Silvio, Suwabe, Tatsuya, Gevers, Tom J G, Cardinale, Vincenzo, Drenth, Joost P H, and Lantinga, Marten A

Published
2024
Full Text
View/download PDF

2. GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study

Author

Rodríguez-Perálvarez, Manuel Luis, de la Rosa, Gloria, Gómez-Orellana, Antonio Manuel, Aguilera, María Victoria, Pascual Vicente, Teresa, Pereira, Sheila, Ortiz, María Luisa, Pagano, Giulia, Suarez, Francisco, González Grande, Rocío, Cachero, Alba, Tomé, Santiago, Barreales, Mónica, Martín Mateos, Rosa, Pascual, Sonia, Romero, Mario, Bilbao, Itxarone, Alonso Martín, Carmen, Otón, Elena, González Diéguez, Luisa, Espinosa, María Dolores, Arias Milla, Ana, Blanco Fernández, Gerardo, Lorente, Sara, Cuadrado Lavín, Antonio, Redín García, Amaya, Sánchez Cano, Clara, Cepeda-Franco, Carmen, Pons, José Antonio, Colmenero, Jordi, Guijo-Rubio, David, Otero, Alejandra, Amador Navarrete, Alberto, Romero Moreno, Sarai, Rodríguez Soler, María, Hervás Martínez, César, and Gastaca, Mikel

Published
2024
Full Text
View/download PDF

6. Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

Author

Rodríguez-Perálvarez, Manuel, Colmenero, Jordi, González, Antonio, Gastaca, Mikel, Curell, Anna, Caballero-Marcos, Aránzazu, Sánchez-Martínez, Ana, Di Maira, Tommaso, Herrero, José Ignacio, Almohalla, Carolina, Lorente, Sara, Cuadrado-Lavín, Antonio, Pascual, Sonia, López-Garrido, María Ángeles, González-Grande, Rocío, Gómez-Orellana, Antonio, Alejandre, Rafael, Zamora-Olaya, Javier, and Bernal-Bellido, Carmen

Published
2022
Full Text
View/download PDF

8. Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies.

Author

Mauro, Ezequiel, Sanduzzi-Zamparelli, Marco, Jutras, Gabrielle, Garcia, Raquel, Soler Perromat, Alexandre, Llarch, Neus, Holguin Arce, Victor, Ruiz, Pablo, Rimola, Jordi, Lopez, Eva, Ferrer-Fàbrega, Joana, García-Criado, Ángeles, Colmenero, Jordi, Lai, Jennifer C., and Forner, Alejandro

Subjects
PATIENT selection, PUBLIC health surveillance, NURSES, OCCUPATIONAL roles, CANCER relapse, SURVIVAL rate, FRAIL elderly, IMMUNOTHERAPY, CANCER patients, TREATMENT effectiveness, ALLIED health personnel, NURSE practitioners, MEDICAL radiology, HEPATOCELLULAR carcinoma, LIVER transplantation, COMORBIDITY, IMMUNOSUPPRESSION, HEALTH care teams
Abstract

Simple Summary: Liver transplantation (LT) is one of the primary treatments for hepatocellular carcinoma (HCC) and significantly improves patient survival. However, the application of LT for HCC faces challenges owing to advancements in cancer-specific treatments and increased patient comorbidities. This review explores the current controversies and advancements in LT for HCC, focusing on managing comorbidities, the impact of frailty, selection criteria, the role of radiology, and the potential use of immunotherapy. We emphasize the importance of immunosuppression management and surveillance for HCC recurrence. A multidisciplinary approach is crucial to optimize the outcomes of patients with HCC undergoing LT, ensuring comprehensive care and improved survival rates. Liver transplantation (LT) remains one of the most effective treatments for hepatocellular carcinoma (HCC) and significantly enhances patient survival. However, the application of LT for HCC faces challenges owing to advancements in cancer-specific treatment modalities and the increased burden of patients' comorbidities. This narrative review explores current controversies and advancements in LT for HCC. Key areas of focus include the management of comorbidities and patient education by advanced practice nurses, impacts of frailty on waitlists and post-LT outcomes, selection criteria for LT in the era of new downstaging tools, role of radiology in patient selection, and implications of potential immunotherapy use both before and after LT. Additionally, the importance of immunosuppression management with strategies aimed at minimizing rejection while considering the risk of HCC recurrence and the role of surveillance for HCC recurrence is highlighted. This review also underscores the importance of a multidisciplinary approach for optimizing outcomes in patients with HCC undergoing LT. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. CACS, CCTA and mCAD‐LT score in the pre‐transplant assessment of coronary artery disease and the prediction of post‐transplant cardiovascular events.

Author

Pagano, Giulia, Sastre, Lydia, Blasi, Annabel, Brugaletta, Salvatore, Mestres, Judit, Martinez‐Ocon, Julia, Ortiz‐Pérez, Jose T., Viñals, Clara, Prat‐Gonzàlez, Susanna, Rivas, Eva, Perea, Rosario J., Rodriguez‐Tajes, Sergio, Muxí, África, Ortega, Emilio, Doltra, Ada, Ruiz, Pablo, Vidal, Bàrbara, Martínez‐Palli, Graciela, Colmenero, Jordi, and Crespo, Gonzalo

Subjects
CORONARY artery disease, CORONARY artery calcification, CORONARY angiography, LIVER transplantation, FAMILY history (Medicine)
Abstract

Background: The optimal cardiovascular assessment of liver transplant (LT) candidates is unclear. We aimed to evaluate the performance of CT‐based coronary tests (coronary artery calcium score [CACS] and coronary CT angiography [CCTA]) and a modification of the CAD‐LT score (mCAD‐LT, excluding family history of CAD) to diagnose significant coronary artery disease (CAD) before LT and predict the incidence of post‐LT cardiovascular events (CVE). Methods: We retrospectively analysed a single‐centre cohort of LT candidates who underwent non‐invasive tests; invasive coronary angiography (ICA) was performed depending on the results of non‐invasive tests. mCAD‐LT was calculated in all patients. Results: Six‐hundred‐and‐thirty‐four LT candidates were assessed and 351 of them underwent LT. CACS, CCTA and ICA were performed in 245, 123 and 120 LT candidates, respectively. Significant CAD was found in 30% of patients undergoing ICA. The AUROCs of mCAD‐LT (.722) and CCTA (.654) were significantly higher than that of CACS (.502) to predict the presence of significant CAD. Specificity of the tests ranged between 31% for CCTA and 53% for CACS. Among patients who underwent LT, CACS ≥ 400 and mCAD‐LT were independently associated with the incidence of CVE; in patients who underwent CCTA before LT, significant CAD at CCTA also predicted post‐LT CVE. Conclusion: In this cohort, mCAD‐LT score and CT‐based tests detect the presence of significant CAD in LT candidates, although they tend to overestimate it. Both mCAD‐LT score and CT‐based tests classify LT recipients according to their risk of post‐LT CVE and can be used to improve post‐LT risk mitigation. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

Author

Belli, Luca S., Fondevila, Constantino, Cortesi, Paolo A., Conti, Sara, Karam, Vincent, Adam, Rene, Coilly, Audrey, Ericzon, Bo Goran, Loinaz, Carmelo, Cuervas-Mons, Valentin, Zambelli, Marco, Llado, Laura, Diaz-Fontenla, Fernando, Invernizzi, Federica, Patrono, Damiano, Faitot, Francois, Bhooori, Sherrie, Pirenne, Jacques, Perricone, Giovanni, Magini, Giulia, Castells, Lluis, Detry, Oliver, Cruchaga, Pablo Mart, Colmenero, Jordi, Berrevoet, Frederick, Rodriguez, Gonzalo, Ysebaert, Dirk, Radenne, Sylvie, Metselaar, Herold, Morelli, Cristina, De Carlis, Luciano G., Polak, Wojciech G., and Duvoux, Christophe

Published
2021
Full Text
View/download PDF

14. Focusing on Ischemic Reperfusion Injury in the New Era of Dynamic Machine Perfusion in Liver Transplantation

Author

Chullo, Gabriela, Panisello-Roselló, Arnau, Marquez, Noel, Colmenero, Jordi, Brunet, Merce, Pera, Miguel, Roselló-Catafau, Joan, Bataller, Ramon, García-Valdecasas, Juan Carlos, Fundora, Yiliam, Chullo, Gabriela, Panisello-Roselló, Arnau, Marquez, Noel, Colmenero, Jordi, Brunet, Merce, Pera, Miguel, Roselló-Catafau, Joan, Bataller, Ramon, García-Valdecasas, Juan Carlos, and Fundora, Yiliam

Abstract

Liver transplantation is the most effective treatment for end-stage liver disease. Transplant indications have been progressively increasing, with a huge discrepancy between the supply and demand of optimal organs. In this context, the use of extended criteria donor grafts has gained importance, even though these grafts are more susceptible to ischemic reperfusion injury (IRI). Hepatic IRI is an inherent and inevitable consequence of all liver transplants; it involves ischemia-mediated cellular damage exacerbated upon reperfusion and its severity directly affects graft function and post-transplant complications. Strategies for organ preservation have been constantly improving since they first emerged. The current gold standard for preservation is perfusion solutions and static cold storage. However, novel approaches that allow extended preservation times, organ evaluation, and their treatment, which could increase the number of viable organs for transplantation, are currently under investigation. This review discusses the mechanisms associated with IRI, describes existing strategies for liver preservation, and emphasizes novel developments and challenges for effective organ preservation and optimization.

Published
2024

17. Profilaxis y tratamiento de la infección por virus de la hepatitis B en el trasplante hepático. VII Documento de consenso de la Sociedad Española de Trasplante Hepático

Author

Álvarez, Carolina Almohalla, Comellas, Mª Carme Baliellas, Baena, Pilar Barrera, Fusté, Lluis Castells, Conde, Gonzalo Crespo, Martínez, Valentín Cuervas-Mons, García, Emilio Fábrega, Ramos, José Ramón Fernández, González, Miguel Juan García, Diéguez, Luisa González, Santos, José Ignacio Herrero, Llanillo, Loreto Hierro, Romero, Maria Isabel Monge, López, Mª Flor Nogueras, Antón, Esteban Otero, Ferreiro, Alejandra Otero, Nieto, Elena Otón, Bartolomé, Sonia Pascual, Sánchez, Maria Luisa Ortiz, Castillo, Martín Prieto, Cristóbal, Mario Romero, Aullo, Trinidad Serrano, Fernández, Inmaculada, Pascasio, Juan Manuel, and Colmenero, Jordi

Published
2020
Full Text
View/download PDF

20. Impact of SARS-CoV-2 Infection on Humoral and Cellular Immunity in a Cohort of Vaccinated Solid Organ Transplant Recipients

Author

Ayala-Borges, Bernardo, primary, Escobedo, Miguel, additional, Egri, Natalia, additional, Herrera, Sabina, additional, Crespo, Marta, additional, Mirabet, Sonia, additional, Arias-Cabrales, Carlos, additional, Vilella, Anna, additional, Palou, Eduard, additional, Mosquera, María M., additional, Pascal, Mariona, additional, Colmenero, Jordi, additional, Farrero, Marta, additional, and Bodro, Marta, additional

Published
2023
Full Text
View/download PDF

22. De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management—Guidelines From the ILTS-SETH Consensus Conference

Author

Colmenero, Jordi, Tabrizian, Parissa, Bhangui, Prashant, Pinato, David James, Rodríguez-Perálvarez, Manuel L., Sapisochin, Gonzalo, Bhoori, Sherrie, Pascual, Sonia, Senzolo, Marco, Al-Adra, David, Herrero, J. Ignacio, Petrowsky, Henrik, Dawson, Laura A., Hosni, Ali, Kutzke, Jade L., Gastaca, Mikel, and Watt, Kymberly D.

Published
2022
Full Text
View/download PDF

24. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial

Author

Solà, Elsa, Solé, Cristina, Simón-Talero, Macarena, Martín-Llahí, Marta, Castellote, José, Garcia-Martínez, Rita, Moreira, Rebeca, Torrens, Maria, Márquez, Francisca, Fabrellas, Núria, de Prada, Gloria, Huelin, Patrícia, Lopez Benaiges, Eva, Ventura, Meritxell, Manríquez, Marcela, Nazar, André, Ariza, Xavier, Suñé, Pilar, Graupera, Isabel, Pose, Elisa, Colmenero, Jordi, Pavesi, Marco, Guevara, Mónica, Navasa, Miquel, Xiol, Xavier, Córdoba, Joan, Vargas, Victor, and Ginès, Pere

Published
2018
Full Text
View/download PDF

25. Risk Factors for Non-Adherence to Medication for Liver Transplant Patients: An Umbrella Review.

Author

Colmenero, Jordi, Gastaca, Mikel, Martínez-Alarcón, Laura, Soria, Cristina, Lázaro, Esther, and Plasencia, Inmaculada

Subjects
*LIVER transplantation, *PATIENT compliance, *TRANSPLANTATION of organs, tissues, etc., *SOCIODEMOGRAPHIC factors, *UMBRELLAS
Abstract

Background/Objectives: Liver Transplantation (LT) is the second most common solid organ transplantation. Medication adherence on LT patients is key to avoiding graft failure, mortality, and important quality of life losses. The aim of this study is to identify risk-factors for non-adherence to treatment of liver transplant patients according to reliable published evidence. Methods: An umbrella review within the context of adherence to immunosuppressant medication of LT patients, was conducted. The review was performed in accordance with the principles of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines. Results: A total of 11 articles were finally included for the review. Non-adherence factors were identified and allocated using the WHO classification of factors for non-adherence. Each of these groups contains a subset of factors that have been shown to influence adherence to medication, directly or indirectly, according to literature findings. Conclusions: The results of the review indicate that sociodemographic factors, factors related to the patient, factors related to the treatment, condition-related and health system-related factors are good categories of predictors for both adherence and non-adherence to immunosuppressive medication in LT patients. This list of factors may help physicians in the treating and recognizing of patients with a potential risk of non-adherence and it could help in the designing of new tools to better understand non-adherence after LT and targeted interventions to promote adherence of LT patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology

Author

Fernandez, Ainhoa, primary, Cova, Miguel, additional, Rodriguez-Tajes, Sergio, additional, Senosiáin, Maria, additional, Conde, Isabel, additional, Martin-Mateos, Rosa, additional, Gonzalez Dieguez, Maria Luisa, additional, Pascual, Sonia, additional, Fabrega, Emilio, additional, Otero, Alejandra, additional, Corchado, Cristina, additional, Gutierrez, Laura Benitez, additional, Romero, Mario, additional, Colmenero, Jordi, additional, Bustamante, Javier, additional, Berenguer, Marina, additional, Diaz, Fernando, additional, Viso, Luis Menchén, additional, Bañares, Rafael, additional, and Salcedo, Magdalena, additional

Published
2023
Full Text
View/download PDF

40. Haemostasis Patterns in Patients With Acute-on-chronic Liver Failure and Acute Decompensation of Cirrhosis Including Thromboelastometric Tests With and Without the Addition of Protac: a Pilot Study

Author

Calvo, Andrea, primary, Torrente, Miguel Angel, additional, Görlinger, Klaus, additional, Fernandez, Javier, additional, Reverter, Enric, additional, Vidal, Julia, additional, Tassies, Dolors, additional, Colmenero, Jordi, additional, Blasi, Annabel, additional, and Reverter, Juan Carlos, additional

Published
2022
Full Text
View/download PDF

41. TOP-002 Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain

Author

Rodríguez-Perálvarez, Manuel, de la Rosa, Gloria, Gómez-Orellana, Antonio M., Sancho, Victoria Aguilera, Pascual-Vicente, Teresa, Pereira, Sheila, Ortiz, María Luisa, Pagano, Giulia, Suárez, Francisco, González-Grande, Rocio, Cachero, Alba, Tomé, Santiago, Valbuena, Mónica Barreales, Martin-Mateos, Rosa, Pascual, Sonia, Cristóbal, Mario Romero, Bilbao, Itxarone, Martin, Carmen Alonso, Oton, Elena, Dieguez, Maria Luisa Gonzalez, Aguilar, María Dolores Espinosa, Arias, Ana, Blanco, Gerardo, Perez, Sara Lorente, Cuadrado, Antonio, García, Amaya Redín, Cano, Clara Sánchez, Franco, Carmen Cepeda, Pons, Jose Antonio, Colmenero, Jordi, Ferreiro, Alejandra Otero, Aretxabaleta, Nerea Hernández, Moreno, Sarai Romero, Soler, Maria Rodriguez, Hervás, César, and Gastaca, Mikel

Published
2024
Full Text
View/download PDF

42. Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study

Author

Universidad de Sevilla. Departamento de Cirugía, Universidad de Sevilla. CTS664: Cirugía avanzada y transplantes. Terapia celular y bioingeniería aplicada a la cirugía., Caballero Marcos, Aránzazu, Peligros, Isabel, Pérez-Rojas, Judith, Campos Varela, Isabel, Colmenero, Jordi, Gómez Bravo, Miguel Ángel, Marín Gómez, Luis Miguel, Salcedo, Magdalena, Universidad de Sevilla. Departamento de Cirugía, Universidad de Sevilla. CTS664: Cirugía avanzada y transplantes. Terapia celular y bioingeniería aplicada a la cirugía., Caballero Marcos, Aránzazu, Peligros, Isabel, Pérez-Rojas, Judith, Campos Varela, Isabel, Colmenero, Jordi, Gómez Bravo, Miguel Ángel, Marín Gómez, Luis Miguel, and Salcedo, Magdalena

Abstract

To the editor,Diagnosis of sinusoidal obstruction syndrome (SOS) after hematopoietic cell transplantation (HCT) is based on clinical criteria including weight gain, ascites, he-patomegaly, and jaundice.[1] However, clinical and histological features and prognosis of SOS after liver transplantation (LT) seem to differ from SOS after H CT.[2,3] We aimed to determine the characteristics and outcomes of SOS after LT.

Published
2022

43. Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

Author

Universidad de Sevilla. Departamento de Cirugía, Universidad de Sevilla. CTS664: Cirugía avanzada y trasplantes. Terapia celular y bioingeniería aplicada a la cirugía., Rodríguez-Perálvarez, Manuel, Colmenero, Jordi, González, Antonio, Gastaca, Mikel, Curell, Anna, Caballero Marcos, Aránzazu, Gómez Bravo, Miguel Ángel, Cepeda Franco, Carmen, Universidad de Sevilla. Departamento de Cirugía, Universidad de Sevilla. CTS664: Cirugía avanzada y trasplantes. Terapia celular y bioingeniería aplicada a la cirugía., Rodríguez-Perálvarez, Manuel, Colmenero, Jordi, González, Antonio, Gastaca, Mikel, Curell, Anna, Caballero Marcos, Aránzazu, Gómez Bravo, Miguel Ángel, and Cepeda Franco, Carmen

Abstract

Cancer is the leading cause of death after liver transplantation (LT). This multicenter case–control nested study aimed to evaluate the effect of maintenance immunosuppres sion on post-LT malignancy. The eligible cohort included 2495 LT patacrolimus-based immunosuppression. After 13 922 person/years follow-up, 425 patients (19.7%) developed malignancy (cases) and were matched with 425 controls by propensity score based on age, gender, smoking habit, etiology of liver disease, and hepatocellular carcinoma (HCC) before LT. The independent predictors of post-LT malignancy were older age (HR = 1.06 [95% CI 1.05–1.07]; p < .001), male sex (HR = 1.50 [95% CI 1.14–1.99]), smoking habit (HR = 1.96 [95% CI 1.42–2.66]), and alcoholic liver disease (HR = 1.53 [95% CI 1.19–1.97]). In selected cases and controls (n = 850), the immunosuppression protocol was similar (p = .51). An increased cumulative exposure to tacrolimus (CET), calculated by the area under curve of trough concentrations, was the only immunosuppression-related predictor of post-LT malignancy after controlling for clinical features and baseline HCC (CET at 3 months p = .001 and CET at 12 months p = .004). This effect was consistent for de novo malignancy (after excluding HCC recurrence) and for internal neoplasms (after excluding non-melanoma skin cancer). Therefore, tacrolimus minimization, as monitored by CET, is the key to modulate immunosuppression in order to prevent cancer after LT.

Published
2022

44. Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study

Author

Caballero‐Marcos, Aránzazu, primary, Peligros, Isabel, additional, Pérez‐Rojas, Judith, additional, Campos‐Varela, Isabel, additional, Colmenero, Jordi, additional, Gómez‐Bravo, Miguel Ángel, additional, Justo, Iago, additional, Otero, Alejandra, additional, Molina‐Pérez, Esther, additional, González‐Diéguez, Luisa, additional, Baliellas, Carme, additional, Romero‐Cristobal, Mario, additional, Aguilera, Victoria, additional, Castells, Lluís, additional, Díaz, Alba, additional, Marín‐Gómez, Luis Miguel, additional, Loinaz, Carmelo, additional, Bañares, Rafael, additional, and Salcedo, Magdalena, additional

Published
2022
Full Text
View/download PDF

45. Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation

Author

Sastre, Lydia, primary, García, Raquel, additional, Viñals, Clara, additional, Amor, Antonio J., additional, Yago, Gema, additional, Hervás, Alicia, additional, Sánchez, Lorena, additional, Trabal, Joan, additional, Molero, Judit, additional, Escudé, Laia, additional, Pagano, Giulia, additional, Blasco, Miquel, additional, Gilabert, Rosa, additional, Ruiz, Pablo, additional, Colmenero, Jordi, additional, Navasa, Miquel, additional, Ortega, Emilio, additional, and Crespo, Gonzalo, additional

Published
2022
Full Text
View/download PDF

46. Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study

Author

Caballero Marcos, Aránzazu, Peligros, Isabel, Pérez-Rojas, Judith, Campos Varela, Isabel, Colmenero, Jordi, Gómez Bravo, Miguel Ángel, Marín Gómez, Luis Miguel, Salcedo, Magdalena, Universidad de Sevilla. Departamento de Cirugía, and Universidad de Sevilla. CTS664: Cirugía avanzada y transplantes. Terapia celular y bioingeniería aplicada a la cirugía.

Subjects
Liver transplantation, Sinusoidal obstruction syndrome
Abstract

To the editor,Diagnosis of sinusoidal obstruction syndrome (SOS) after hematopoietic cell transplantation (HCT) is based on clinical criteria including weight gain, ascites, he-patomegaly, and jaundice.[1] However, clinical and histological features and prognosis of SOS after liver transplantation (LT) seem to differ from SOS after H CT.[2,3] We aimed to determine the characteristics and outcomes of SOS after LT.

Published
2022

47. Primary herpes simplex virus type 1 infection with acute liver failure in solid organ transplantation: Report of three cases and review

Author

Arana, Carolt, primary, Cofan, Frederic, additional, Ruiz, Pablo, additional, Hermida, Evelyn, additional, Fernández, Javier, additional, Colmenero, Jordi, additional, Forns, Xavier, additional, Escude, Laia, additional, Cucchiari, David, additional, Moreno, Asunción, additional, Bodro, Marta, additional, Herrera, Sabina, additional, Rodriguez, Camino, additional, Paredes, David, additional, and Diekmann, Fritz, additional

Published
2022
Full Text
View/download PDF

48. The Role of Arterial Stiffness in the Estimation of Cardiovascular Risk in Liver Transplant Recipients

Author

Sastre, Lydia, primary, García, Raquel, additional, Gándara, Julián-Gonzalo, additional, Fernández-Llama, Patricia, additional, Amor, Antonio J., additional, Sierra, Cristina, additional, Escudé, Laia, additional, Ruiz, Pablo, additional, Colmenero, Jordi, additional, Ortega, Emilio, additional, Navasa, Miquel, additional, and Crespo, Gonzalo, additional

Published
2021
Full Text
View/download PDF

49. De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management—Guidelines From the ILTS-SETH Consensus Conference

Author

Colmenero, Jordi, primary, Tabrizian, Parissa, additional, Bhangui, Prashant, additional, Pinato, David James, additional, Rodríguez-Perálvarez, Manuel L., additional, Sapisochin, Gonzalo, additional, Bhoori, Sherrie, additional, Pascual, Sonia, additional, Senzolo, Marco, additional, Al-Adra, David, additional, Herrero, J. Ignacio, additional, Petrowsky, Henrik, additional, Dawson, Laura A., additional, Hosni, Ali, additional, Kutzke, Jade L., additional, Gastaca, Mikel, additional, and Watt, Kymberly D., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results